BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4822898)

  • 1. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
    Guinan P; Ablin RJ; Sadoughi N; Bush IM
    J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen and bladder carcinoma.
    Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
    J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
    Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoembryonic antigen in the urine of patients with urothelial carcinoma.
    Hall RR; Laurence DJ; Darcy D; Stevens U; James R; Roberts S; Munro Neville A
    Br Med J; 1972 Sep; 3(5827):609-11. PubMed ID: 5071696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
    Coombers GB; Hall RR; Laurence JR; Neville AM
    Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
    Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
    Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
    James K; Alroy J; Miller AW; Flanagan M
    Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma.
    Guinan P; John T; Sadoughi N; Ablin RJ; Bush I
    J Urol; 1974 Mar; 111(3):350-2. PubMed ID: 4813575
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer.
    Fraser RA; Ravry MJ; Segura JW; Go VL
    J Urol; 1975 Aug; 114(2):226-9. PubMed ID: 1159914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
    Yang SC
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate antigen 19-9 and carcinoembryonic antigen-producing transitional cell carcinoma of the ureter and bladder: a case report.
    Sakai H; Toyofuku K; Yogi Y; Minami Y; Kanetake H; Saito Y
    J Urol; 1993 Jul; 150(1):182-4. PubMed ID: 8510248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.